In conclusion, we propose that inhibition of β-cell metabolism in diabetes is mediated by accumulation of one or more glycolytic metabolites lying between PFK and GAPDH (i.e., F1,6BP, DHAP or GA3P) (Fig. 10). Here, GAPDH is linked to diabetes mellitus.